XML 38 R25.htm IDEA: XBRL DOCUMENT v3.22.2
FAIR VALUE MEASUREMENTS (Tables)
6 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities Measured at Fair Value
The following table summarizes the types of assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy:
June 30, 2022December 31, 2021
(in millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:
Available-for-sale debt securities:
U.S. treasury securities$427 $— $— $427 $407 $— $— $407 
U.S. government agencies securities— — — — — — 
Non-U.S. government securities— 31 — 31 — 50 — 50 
Certificates of deposit— 88 — 88 — 249 — 249 
Corporate debt securities— 1,386 — 1,386 — 1,363 — 1,363 
Residential mortgage and asset-backed securities— 358 — 358 — 424 — 424 
Equity securities:
Money market funds3,094 — — 3,094 3,661 — — 3,661 
Equity investment in Galapagos NV (“Galapagos”)935 — — 935 931 — — 931 
Equity investment in Arcus Biosciences, Inc. (“Arcus”)350 — — 350 559 — — 559 
Other publicly traded equity securities117 — — 117 331 — — 331 
Deferred compensation plan215 — — 215 261 — — 261 
Foreign currency derivative contracts— 136 — 136 — 80 — 80 
Total$5,138 $1,999 $— $7,137 $6,150 $2,170 $— $8,320 
Liabilities:
Liability for MYR GmbH (“MYR”) contingent consideration$— $— $306 $306 $— $— $317 $317 
Deferred compensation plan215 — — 215 261 — — 261 
Foreign currency derivative contracts— — — — 
Total$215 $$306 $523 $261 $$317 $583 
Summary of Change in Fair Value of Contingent Consideration
The following table summarizes the change in fair value of our contingent consideration:
Three Months EndedSix Months Ended
June 30,June 30,
(in millions)2022202120222021
Beginning balance$322 $341 $317 $— 
Additions— — — 341 
Changes in valuation assumptions— (1)11 (1)
Effect of foreign exchange remeasurement(16)(6)(22)(6)
Ending balance
$306 $334 $306 $334